Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(NasdaqGM:VERA), BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 228,750 shares of Class A common stock and restricted stock units (RSUs) underlying […]